RBC Aging and Disease {#S1}
=====================

Tissue oxygenation depends on hemoglobin as much as on red blood cell (RBC) characteristics such as metabolism, communication with the immune system, deformability and aggregation behavior. Many if not all of these processes depend on the organization of the RBC membrane that enables the complex, dynamic interactions between the cell membrane and various intracellular and extracellular molecules. Studies of inborn errors of metabolism and membrane protein composition, in combination with the structural and functional changes that occur during RBC aging, have led to a membrane-centered molecular understanding of red blood cell function and survival, and of the role of membrane molecules in cell morphology and membrane organization. Modification of the integral membrane protein band 3 plays a central role in the weakening of the cytoskeleton/membrane interaction at the ankyrin complex, which underlies the generation of microvesicles ([@B9], [@B8]; [@B30]). Vesiculation results in the loss of approximately 20% of the hemoglobin, a decrease of 30% in MCV and a concomitant increase in 15% in MCHC ([@B38]). The associated changes in cell density and volume enable a clear separation of RBCs according to cell age ([@B7]; [@B38], [@B39]). The accumulation of band 3-derived neoantigens and phosphatidylserine on microvesicles induces their fast disappearance from the circulation, prevents inflammation and thrombosis. Overall, shedding of defective components through vesiculation prevents untimely removal of otherwise functional RBCs ([@B39]; [@B8]; [@B1]; [@B23], [@B22]). Nevertheless, old and pathological RBCs are more prone to display removal signals or break down when exposed to osmotic or mechanical stress ([@B10]; [@B25]).

Deformability {#S2}
=============

In the course of our investigations on the functional consequences of aging-associated or pathology-related changes in membrane organization, we noticed multiple changes in deformability and aggregation ([@B13], [@B11], [@B14], [@B12]; [@B24]). Deformability is a critical determinant of RBC function, because of the extensive change in cell shape required for efficient passage through the capillaries and the spleen. Indeed, physiological aging of RBCs *in vivo* is associated with a pronounced decrease in their deformability ([@B7]). Also, many RBC-centered pathologies such as deficiencies in metabolic enzymes, altered hemoglobins, and mutations in membrane proteins affect the same processes that play a critical role in physiological aging, and are associated with decreased deformability, as well ([@B1]; [@B31]). This may be due directly to weakening of the interactions between membrane and/or cytoskeleton proteins, or to the resulting loss of membrane by vesiculation ([@B26]). A decrease in the capacity to deform will lead to a decrease in tissue perfusion and oxygenation, and thereby contribute to the pathophysiology.

Aggregation {#S3}
===========

The same RBC characteristics that determine RBC deformability also play a role in their interaction with plasma proteins, other RBCs, leukocytes and platelets, and the vascular lining ([@B6]). At low shear stress or upon removal of external forces, RBCs form rouleaux (stacks of RBCs) and three-dimensional aggregates. Aggregate formation affects tissue perfusion and has an impact on hemostasis, probably by affecting the flow behavior of platelets and leukocytes and their interaction with the vascular endothelium ([@B2]; [@B36]). Aggregation is likely to be determined for a major part by low-affinity interactions of RBCs with plasma proteins such as fibrinogen and immunoglobulins ([@B33]; [@B37]). In addition, changes in aggregation are often accompanied by changes in deformability, and sometimes by changes in cell shape as well ([@B40]; [@B29]).

Deformability and Aggregation {#S4}
=============================

Approximately one fifth of the recent papers on RBC deformability also present data on aggregation and *vice versa*, mostly in pathological conditions, but there are few, if any, that try and determine the common factors or mechanisms underlying the observed changes ([@B40]). In the course of our studies on RBC homeostasis in health and disease, we have accumulated deformability and/or aggregation data of RBCs with various biological backgrounds, such as RBCs of different ages isolated from the circulation of healthy donors ([@B39]; [@B24]), RBCs of different storage periods in the blood bank ([@B13]), acanthocytes and otherwise misshapen RBCs from patients with neuroacanthocytosis ([@B17]; [@B14]), and RBCs treated with various membrane organization-affecting agents ([@B20]; [@B12]). In order to shed more light on the mechanisms that underly aging-associated and pathology-related decreases in RBC function, we used the data obtained in these studies to perform a quantitative correlation analysis of the commonly used deformability and aggregation parameters.

It has been shown before that there is a strong linear association between the extent as expressed by the aggregation index (AI) and t~1/2~, the speed by which aggregates form ([@B4]). Analysis of all accumulated data mentioned above confirms this finding, with a Pearson correlation coefficient between AI and t~1/2~ of -- 0.87 ([Table 1](#T1){ref-type="table"}) meaning that if large aggregates are formed, they form faster. There is also a positive correlation between the relaxation time Tr, i.e., the time needed by the RBCs to regain their normal shape from being elongated in the direction of the flow after undergoing a shear rate of 500 s^--1^, and the AI (*r* = 0.43), and between the Tr and the t~1/2~ (*r* = −0.31), indicating that stiffness of RBCs promotes aggregate formation and enhances the speed by which aggregates form. Furthermore, our data show a strong negative correlation (*r* = −0.71) between the calculated maximal deformability EI~max~ and SS~1/2~, the shear stress at which half the EI~max~ is reached ([Table 1](#T1){ref-type="table"}), demonstrating that elongation is a function of less resistance to deformation. A similar relationship between these deformability parameters has been described for RBCs that had been treated with various concentrations of glutaraldehyde *in vitro* ([@B3]; [@B40]).

###### 

Determination of the correlation between deformability and aggregation.

                                     *r*        *R*^2^    *P* (two-tailed)   *N*
  ---------------------------------- ---------- --------- ------------------ -----
  EI~max~ vs. SS~1/2~                --0.7085   0.502     \<0.0001           140
  AI vs. t~1/2~                      --0.8662   0.7504    \<0.0001           121
  EI~max~ vs. AI                     0.2126     0.0452    0.0192             121
  EI~max~ vs. AMP                    --0.119    0.01415   0.1937             121
  EI~max~ vs. t~1/2~                 --0.1705   0.02906   0.0616             121
  SS~1/2~ vs. AI                     --0.2607   0.06794   0.0039             121
  SS~1/2~ vs. AMP                    0.3482     0.1212    \<0.0001           121
  SS~1/2~ vs. t~1/2~                 0.2511     0.06303   0.0055             121
  Tr vs. EI~max~                     0.5198     0.2702    \<0.0001           121
  Tr vs. AI                          0.4282     0.1834    \<0.0001           121
  Tr vs. AMP                         --0.4547   0.2067    \<0.0001           121
  Tr vs. t1/2                        --0.3129   0.09791   0.0005             121
  Tr vs. SS~1/2~                     --0.5874   0.3451    \<0.0001           121
  Ratio \[SS~1/2~/EI~max~\] vs. AI   --0.2592   0.06716   0.0041             121
  Ratio vs. AMP                      0.2647     0.07006   0.0033             121
  Ratio vs. t~1/2~                   0.2392     0.05723   0.0082             121
  Ratio vs. Tr                       --0.5918   0.3502    \<0.0001           121
  Ratio vs. EI~max~                  --0.8566   0.7338    \<0.0001           140
  Ratio vs. SS~1/2~                  0.9658     0.9328    \<0.0001           140

RBCs were isolated and their deformability and aggregation characteristics were determined by ektacytometry using a laser-assisted optical rotational cell analyzer (Lorrca Maxis, RR Mechatronics, Hoorn, Netherlands) as described previously (

Cluitmans et al., 2012

;

Da Costa et al., 2016

). Deformability was assessed using the elongation index (EI) at various shear stress (0.3 to 30 Pa), yielding the maximal elongation (EI

max

), i.e., the calculated EI at infinite shear stress, and SS

1/2

, i.e., the shear stress at which EI is half of the EI

max

. Aggregation characteristics are assessed using: (1) the shape recovery time Tr, i.e., the time needed by the RBCs to regain their normal shape (

Dobbe et al., 2003

) after undergoing a shear rate of 500 s

--1

(shear stress of 1.5 Pa); (2) the aggregation index AI, defined as the decrease in intensity of scattered light during 10 s following disaggregation; (3) the t

1/2

, the rate at which aggregates are formed (

Da Costa et al., 2016

). Blood was obtained with informed consent and the studies were carried out as described before (

De Franceschi et al., 2011

;

Dinkla et al., 2012

;

Cluitmans et al., 2015

,

2016

), in accordance with the CCMO guidelines of the Medical Ethical Committee of the Radboud University Medical Center (file numbers 2007-148, 2013-381, 2018-4421).

Aggregability is affected by cellular factors such as cell morphology and surface properties, and by the environment. This is illustrated by the effect of RBC age on aggregation characteristics, the variability in RBC aggregability between donors and between species, and by the findings on the correlation between plasma viscosity and aggregation ([@B33]; [@B34]). However, the underlying mechanisms are far from clear. Since cell shape and membrane composition are closely related to deformability as well, we analyzed the association between the main deformability and aggregation parameters. The strongest correlation between aggregation and deformability parameters was found between the shape recovery relaxation parameter Tr and the deformability characteristics SS~1/2~ (*r* = −0.59) and EI~max~ (*r* = 0.52), meaning that a rapid recovery from relaxation correlates with a low shear stress required for half maximal elongation and with a strong maximal elongation. Indeed, although Tr is one of the outcome of the aggregation measurement protocol of the Lorrca (RR Mechatronics, Hoorn, Netherlands), Tr is actually a deformability parameter. These findings strengthen the relationship between RBC relaxation and deformation capacity, as observed for RBCs in a microcapillary network-mimicking microfluidics device ([@B11]). Smaller, but equally statistically significant correlation coefficients were found between AI and SS~1/2~ (*r* = −0.26) and between SS~1/2~ and t~1/2~ (*r* = 0.25; [Table 1](#T1){ref-type="table"}). This relationship between deformation at a shear stress of 2--3 Pa, which is in the same range as the shear stress that RBCs undergo in microcapillaries ([@B28]), and the aggregability is strengthened by the statistically significant correlation (*r* = 0.35) between SS~1/2~ and the extent of aggregation AMP ([Table 1](#T1){ref-type="table"}).

It has been argued that the deformability parameters SS~1/2~ and EI~max~ as such may not always yield satisfactory, relevant information on deformability properties, especially in the case of large changes in EI~max~. The SS~1/2~/EI~max~ ratio is much less affected by such changes, and may be more suitable when comparing RBCs from various populations or with different clinical backgrounds ([@B3]). Applying this ratio, we found statistically significant correlations between deformability and the aggregation parameters AI, AMP, t~1/2~ and Tr, that were higher than using SS~1/2~ and EI~max~ separately ([Table 1](#T1){ref-type="table"}).

Taken together, our quantitative analyses show that there are a several statistically significant correlations between deformability and aggregation parameters. However, the biological relevance of these correlations remains to be established. Based on the *R*^2^ values, there is only a weak relationship between the deformability and aggregation parameters SS~1/2~ and AMP, i.e., maximally 25 percent of the variance in the shear stress at which half of the maximal deformability is reached, is explained by the variance in the extent of aggregation, and vice versa ([Table 1](#T1){ref-type="table"}). The relationship between Tr, measured as part of the aggregation analysis, and the deformability parameter SS~1/2~ is considerably stronger ([Table 1](#T1){ref-type="table"}), supporting the interpretation of the relaxation time Tr as a deformability characteristic.

It has been speculated that phosphorylation of band 3 is the main molecular determinant controlling deformability and aggregation ([@B5]). Band 3 plays a key role in many aspects of the RBC aging process, which is associated with alterations in deformability and aggregation ([@B9]). Further support for this hypothesis comes from the observation that the formation of acanthocytes and otherwise misshapen RBCs in patients with neuroacanthocytosis is strongly associated with alterations in the Lyn kinase-controlled phosphorylation of membrane proteins including band 3 ([@B17], [@B16]). Thus, to obtain further information on the role of band 3 (phosphorylation) on functional characteristics, we examined the relationship between cell morphology, deformability and aggregability in RBCs from patients with various forms of neuroacanthocytosis ([@B17]; [@B14]; [Figure 1](#F1){ref-type="fig"}).

![Brightfield microscopy of RBCs and RBC aggregates. Microscopic analyses of RBCs and aggregates were performed by a ZOE Fluorescent Cell Imager (Bio-Rad Laboratories, Hercules, CA, United States). Packed RBCs (1 μL) were resuspended in 199 μL of non-aggregating solution (Ringer) and transferred to an ibidi μ-slide. For aggregation analysis, 2.5 μL of packed RBCs were resuspended in 247.5 μL of plasma. The sample was transferred to an ibidi μ-slide and left for 120 s to allow the RBCs to aggregate. **(A)** control RBCs; **(B)** aggregates of control RBCs; **(C)** RBCs from a neuroacanthocytosis patient; **(D)** RBCs of a neuroacanthocytosis patient after aggregation; **(E,F)**, control RBCs after treatment with orthovanadate before **(E)** and after aggregation **(F)**; **(G,H)** control RBCs after treatment with DIDS before **(G)** and after aggregation **(H)**. The arrows indicate the echinocytes, the large arrowheads point to misshapen RBCs. Treatments were performed as described before ([@B13]). The length of the bar is 25 μm. Blood was obtained with informed consent and the studies were carried out as described before ([@B17]; [@B20]; [@B14], [@B12]), in accordance with the CCMO guidelines of the Medical Ethical Committee of the Radboud University Medical Center (file numbers 2007-148, 2013-381, 2018-4421).](fphys-11-00288-g001){#F1}

In spite of their aberrant morphology ([Figure 1C](#F1){ref-type="fig"}), acanthocytes deform and relax normally when passing through a microfluidics system that mimics the dimensions (7 μm) and shear stress (2 Pa) of capillaries. However, they are retained when squeezing through a spleen-mimicking device, which is consistent with a decreased deformability ([@B14]). The negative correlation that was observed between the deformability parameters EI~max~ and SS~1/2~ for control RBCs was observed for neuroacanthocytosis RBCs as well (*r* = −0.59), as was the correlation between the different aggregation parameters AI and t1/2 (*r* = −0.95; [Table 2](#T2){ref-type="table"}). RBCs from neuroacanthocytosis patients, however, displayed lower Tr values than control RBCs (53 ± 5 vs. 116 ± 7 ms), indicating that these RBCs are more stiff. The neuroacanthocytosis RBCs did not show the correlations between Tr and SS~1/2~ observed for control RBCs ([Table 2](#T2){ref-type="table"}). Also, there were no statistically significant correlations between the deformability parameters SS~1/2~ and EI~max~ and the aggregation parameters AI and t~1/2~ for the neuroacanthocytosis RBCs ([Table 2](#T2){ref-type="table"}). In addition, there was no correlation between SS~1/2~ and EI~max~ demonstrating that the intracellular mechanics of these cells is fundamentally different from the one of healthy cells. In contrast, however, a statistically significant correlation was observed between Tr and AMP (the total extent of aggregation), with a correlation coefficient r (0.85) and R^2^ (0.72) that were much higher than those found in control RBCs ([Table 2](#T2){ref-type="table"}). Overall, these findings suggests that the viscoelastic properties of the lipid bilayer that influence relaxation/deformability become much more pronounced when the band 3-mediated interaction between the membrane and the cytoskeleton is weakened, as in the misshapen RBCs of neuroacanthocytosis patients ([@B16]).

###### 

Determination of the correlations between deformability and aggregation parameters of red blood cells from neuroacanthocytosis patients.

                                   *r*         *R*^2^      *P* (two-tailed)   *N*
  -------------------------------- ----------- ----------- ------------------ -----
  EIi~max~ vs. SS~1/2~             --0.5878    0.3455      0.0444             12
  AI vs. t~1/2~                    --0.9539    0.9099      \<0.0001           10
  EImax vs. AI                     0.1266      0.01603     0.7274             10
  EI~max~ vs. AMP                  0.3614      0.1306      0.3048             10
  EI~max~ vs. t~1/2~               --0.03048   0.0009291   0.9334             10
  SS~1/2~ vs. AI                   --0.4562    0.2081      0.1851             10
  SS~1/2~ vs. AMP                  --0.222     0.04928     0.5376             10
  SS~1/2~ vs. t~1/2~               0.4941      0.2442      0.1466             10
  Tr vs. EI~max~                   0.6559      0.4302      0.0395             10
  Tr vs. AI                        0.5728      0.3281      0.0835             10
  Tr vs. AMP                       0.8512      0.7246      0.0018             10
  Tr vs. t~1/2~                    --0.4576    0.2094      0.1836             10
  Tr vs. SS1/2                     --0.4139    0.1713      0.2344             10
  Ratio \[SS1/2/EI~max~\] vs. AI   --0.3864    0.1493      0.27               10
  Ratio vs. AMP                    --0.2781    0.07733     0.4366             10
  Ratio vs. t~1/2~                 0.3596      0.1293      0.3074             10
  Ratio vs. Tr                     --0.5511    0.3037      0.0987             10
  Ratio vs. EI~max~                --0.8103    0.6566      0.0014             12
  Ratio vs. SS~1/2~                0.9449      0.8928      \<0.0001           12

Deformability and aggregation characteristics of the red blood cells from neuroacanthocytosis patients were determined and analyzed as described in the legend to

Table 1

.

Microscopy indicates that for the RBCs from neuroacanthocytosis patients the correlation between the kinetics and extent of aggregation is conserved ([Figure 1](#F1){ref-type="fig"}). However, RBCs from neuroacanthocytosis patiens formed more, irregular aggregates than the RBCs from control donors, and these aggregates were smaller and took longer to form ([Figure 1](#F1){ref-type="fig"}). DIDS-induced changes in the organization of band 3 complexes, and orthovanadate-induced, phosphorylation-associated weakening of the connection between the cytoskeleton and the lipid bilayer not only resulted in altered cell morphology, but also in alterations of the shape and size of their aggregates ([Figure 1](#F1){ref-type="fig"}).

General Discussion and Conclusion {#S5}
=================================

Taken together, the correlations that we found between deformability and aggregation, although weak, suggests that at least one common property is involved in both phenomena. Most of these correlations were absent in the misshapen RBCs of patients with acanthocytosis ([Table 1](#T1){ref-type="table"} vs. [Table 2](#T2){ref-type="table"}). Therefore, the common mechanism is likely to be concentrated around the phosphorylation-controlled binding between the integral membrane protein complexes containing band 3 and the cytoskeleton, that is disturbed in neuroacanthocytosis ([@B17], [@B16]). Data from experimental manipulation of phosphorylation status and from the RBCs of patients with hereditary membranopathies support this hypothesis ([@B12]; [@B26]). Our present analyses indicate that a disturbance in the association between cytoskeleton and membrane affects deformation more than aggregation, thereby reducing the correlation between both processes. A similar conclusion may be drawn from the apparent lack of correlation between deformability and aggregation, for example in red blood cells of various age ([@B7]; [@B13]; of and of patients with diabetes mellitus and coronary artery disease ([@B27]; [@B32]). In addition, our present neuroacanthocytosis data in combination with the data obtained through pharmacological modulation of the band 3 complex, provide analytic approaches for delineating the contribution of various membrane components -- and their interactions -- to deformability and aggregation.

We emphasize that these conclusions are likely to be influenced by the methods and device that are used to measure deformability, and possibly aggregation as well ([@B21]; [@B4]; [@B15]; [@B26]). For example, we have observed that deformability-assessing methods that employ shear stresses and flow conditions similar to those experienced by RBCs in the capillary system, such as a microfluidics device, yield results that are different from those employing larger forces, such as a bead-sorting device and ektacytometry ([@B18]; [@B11], [@B14], [@B12]; [@B15]). In addition, quantitative aggregation measurement by ektacytometry alone is likely to obscure any insight into underlying mechanisms, since the resulting parameters may not always reflect the shape and/or size of the aggregates. One example is the relaxation parameter Tr, which is one of the outcomes of most quantitative aggregation analyses, that shows a higher correlation with deformability than with aggregation parameters ([Table 1](#T1){ref-type="table"}). Simultaneous microscopic analysis may therefore be valuable in distinguishing between the various factors that affect cell-cell interactions. Microscopy of RBCs from various patients or after treatment reveals, in most cases, considerable heterogeneity in cell size and shape ([@B13], [@B14], [@B12]). This heterogeneity may be reflected in variations in the deformability and aggregation parameters, especially in the case of a relatively low number of available patient samples, and may underlie the strong decrease in statistical significance of the correlations between deformability and aggregation for the RBCs observed when comparing the data of control RBCs with those from the neuroacanthocytosis patients (cf. [Tables 1](#T1){ref-type="table"}, [2](#T2){ref-type="table"}). Functional heterogeneity may also be affected by the natural history of the red blood cells and red blood cell fractions, as postulated for the exposure of removal signals and the behavior in a microfluidics device of red blood cells of healthy donors ([@B13], [@B11]; [@B19]), and for the age-associated and disease-related heterogeneity in deformability and aggregation in red blood cells of patients with chronic venous disease ([@B35]).

In conclusion, our current data show clear and rationally accessible correlations between various deformability and aggregation parameters. These correlations are lost in the RBCs of patients with neuroacanthocytosis, thereby identifying band 3 as a key molecular determinant orchestrating both functions.
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